Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

752
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
752
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

490
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
490
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

6.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.2K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

792
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
792
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

525
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
525

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steatotic Liver Disease Subtypes and Advanced Fibrosis as Independent Predictors of Ischemic Stroke in Type 2 Diabetes Mellitus.

Endocrinology and metabolism (Seoul, Korea)·2026
Same author

High-Amplitude and Prolonged Glucose Excursions as a Key Determinant of Discordance Between Glucose Management Indicator and Glycated Hemoglobin in Type 1 Diabetes.

Diabetes care·2026
Same author

Soft Multiaxial Strain Mapping Interface with AI-Driven Decoding for Silent Speech in Noise.

Cyborg and bionic systems (Washington, D.C.)·2026
Same author

Feasibility of a semiautomated, individualized coaching intervention for glycemic management in adults with type 1 diabetes: a pilot randomized controlled trial.

Journal of endocrinological investigation·2026
Same author

Association between body weight time in target range and risk of type 2 diabetes in adults with obesity.

Diabetology & metabolic syndrome·2026
Same author

Universal cryogenic transfer of liquid metal particles in polymers for wafer-scale stretchable integrated electronics.

Nature communications·2026
Same journal

Established machine learning matches tabular foundation models in clinical predictions.

BMC medical informatics and decision making·2026
Same journal

Explainable AI machine learning framework for chronic kidney disease prediction utilizing electronic health records.

BMC medical informatics and decision making·2026
Same journal

Interpretable SHAP-based machine learning framework for patient satisfaction prediction: a case study in Thammasat University Hospital.

BMC medical informatics and decision making·2026
Same journal

Automated generation of structured breast ultrasound reports using BreastViT and ChatGPT.

BMC medical informatics and decision making·2026
Same journal

Shared decision-making and medication adherence among community adults with chronic diseases: a cross-sectional study in Hubei Province, China.

BMC medical informatics and decision making·2026
Same journal

Classification of periapical radiographic findings for root canal therapy decision support using deep neural networks.

BMC medical informatics and decision making·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.4K

A machine-learning approach to predict postprandial hypoglycemia.

Wonju Seo1, You-Bin Lee2, Seunghyun Lee1

  • 1Department of Creative IT engineering, POSTECH, 77, Cheongam-Ro, Nam-Gu, Pohang, 37673, Republic of Korea.

BMC Medical Informatics and Decision Making
|November 8, 2019
PubMed
Summary
This summary is machine-generated.

Predicting postprandial hypoglycemia is crucial for artificial pancreas systems. A random forest machine learning model demonstrated high accuracy in predicting these events using continuous glucose monitoring data.

Keywords:
DiabetesHypoglycemiaMachine-learning approachRisk prediction

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.1K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

Related Experiment Videos

Last Updated: Jan 4, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.4K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.1K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

71.2K

Area of Science:

  • Artificial intelligence in healthcare
  • Diabetes management technology
  • Biomedical signal processing

Background:

  • Accurate hypoglycemia prediction is vital for effective artificial pancreas (AP) systems and continuous glucose monitoring (CGM).
  • While nocturnal hypoglycemia prediction is established, postprandial hypoglycemia remains challenging due to mealtime glucose fluctuations.
  • This study assesses a computationally efficient machine learning algorithm for predicting postprandial hypoglycemia.

Purpose of the Study:

  • To evaluate the feasibility of a user-friendly, efficient machine learning algorithm for postprandial hypoglycemia prediction.
  • To develop and compare the performance of various machine learning models using a unique feature set.
  • To identify the most effective model for predicting postprandial hypoglycemic events.

Main Methods:

  • Retrospective analysis of CGM data from 104 individuals with hypoglycemia alerts.
  • Development of four machine learning models: Random Forest (RF), Support Vector Machine (SVM), K-Nearest Neighbor (KNN), and Logistic Regression.
  • 5-fold cross-subject validation and performance evaluation using Area Under the Curve (AUC) and F1 score.

Main Results:

  • The Random Forest (RF) model achieved the highest performance with an average AUC of 0.966.
  • RF demonstrated superior predictive capabilities for postprandial hypoglycemia compared to other models.
  • Key performance metrics for RF included 89.6% average sensitivity and 91.3% average specificity.

Conclusions:

  • Machine learning algorithms show significant potential for predicting postprandial hypoglycemia.
  • The RF model is a promising candidate for advancing CGM and AP technologies.
  • Further development of RF-based algorithms can enhance the safety and efficacy of diabetes management systems.